Thyroid Hormone Physiology and Pharmacokinetics
Axis, biosynthesis, deiodinases, receptors, and drug interactions
Hypothalamic-Pituitary-Thyroid Axis
Hypothalamus
Thyrotropin-releasing hormone released
→
Pituitary
Thyroid-stimulating hormone secreted
→
Thyroid
T4 and T3 synthesized and secreted
→
Feedback
T3 suppresses thyroid-stimulating hormone at pituitary
Biosynthesis Steps and Drug Targets
Step 1
Sodium-Iodide Symporter
- Concentrates iodide 20–40× plasma
- Basis for radioactive iodine uptake
- Inhibited by perchlorate
Steps 2–3
Thyroid Peroxidase
- Organification of iodide onto thyroglobulin
- Coupling to form T4 and T3
- Blocked by methimazole and propylthiouracil
Regulation
Wolff-Chaikoff Effect
- Iodide excess transiently blocks organification
- Exploited by Lugol's iodine and potassium iodide
- Escape occurs in days via symporter downregulation
Deiodinase Isoforms
Type 1
D1 — Peripheral Tissues
- Liver, kidney, skeletal muscle
- T4 → T3 (peripheral conversion)
- Inhibited by propylthiouracil, amiodarone
Type 2
D2 — Brain and Pituitary
- Pituitary, brain, heart
- Local T4 → T3 for thyroid-stimulating hormone feedback
- Upregulated in hypothyroidism
Type 3
D3 — Placenta / Fetus
- Inactivates T4 and T3 to reverse T3
- Protects fetus from excess thyroid hormone
- Upregulated in critical illness (sick euthyroid)
Key Drug Interactions
Absorption Reducers
Separate by ≥4 Hours
- Calcium, iron, antacids
- Cholestyramine, sucralfate
- Proton pump inhibitors (raise gastric pH)
Metabolism Inducers
Require Dose Increase
- Rifampin — hepatic enzyme induction
- Phenytoin, carbamazepine, phenobarbital
- Dose increase 20–50%; recheck thyroid-stimulating hormone
Amiodarone: Multiple Mechanisms
37% iodine by weight → massive iodine load • Inhibits type 1 deiodinase → raises reverse T3, lowers T3 • Can cause hypothyroidism (most common) or thyrotoxicosis (type 1: iodine-driven; type 2: destructive thyroiditis) • Check thyroid function before starting and every 6 months.